IL6 and breast carcinoma: When RANTES and IL-6 were simultaneously expressed, a more significant increase in the migration of both MCF-7 and MDA-MB-231 cells was observed, as compared to breast cancer cells transfected with RANTES or with IL-6 alone (Figure 2A and 2B).